Review article: immune checkpoint inhibitors and the liver, from therapeutic efficacy to side effects.

Published in: Alimentary pharmacology & therapeutics (2019)

Immune checkpoint inhibitors represent an exciting new class of drugs with currently limited application in malignant and non-malignant liver disease. Caution must be exercised on the emergence of potentially severe immune adverse reactions.

Keyphrases

drug induced
emergency department
adverse drug